Menu
Holocaust Martyrs' and Heroes' Remembrance Day 2017

Holocaust Martyrs' and Heroes' Reme…

​The Holocaust Martyrs' a...

University of Haifa and Rambam Hospital Unveil Partnership and Plans for Twenty-Story ‘Medical Discovery Tower’

University of Haifa and Rambam Hosp…

Strategic partnership bet...

In landmark ruling, US court allows heirs of Jewish art dealers to sue Germany for restitution

In landmark ruling, US court allows…

WJC, A district court in ...

230 Ukrainian Immigrants Arrive in Israel for Passover, Part of Effort to Rescue Embattled Jews

230 Ukrainian Immigrants Arrive in …

JERUSALEM, More than 200 ...

Holocaust survivor, 86, from Brooklyn returning to Auschwitz for 1st time, with Israeli army officers

Holocaust survivor, 86, from Brookl…

Friends of the IDF ‘From ...

Ambassadors Against BDS: 2,000 gather at United Nations HQ in New York in support of Israel

Ambassadors Against BDS: 2,000 gath…

The World Jewish Congress...

World Jewish Congress launches petition to ICRC demanding Hamas return bodies of IDF soldiers

World Jewish Congress launches peti…

NEW YORK - The World Jewi...

PM Netanyahu meets with top Chinese corporate leaders

PM Netanyahu meets with top Chinese…

​The Prime Minister expre...

World Jewish Congress welcomes Swiss lawmakers' push to protect religious communities, end government funding of BDS

World Jewish Congress welcomes Swis…

NEW YORK - World Jewish C...

PM Netanyahu meets with Russian President Putin

PM Netanyahu meets with Russian Pre…

​The threat of radical Sh...

Prev Next
A+ A A-

Safer radiation therapy

 

An Israeli company's biodegradable 'balloon' radically reduces the negative side effects of radiation in cancer treatment.

 

 

By Desmond Bentley
The main drawback of radiation therapy for cancer patients is that it harms healthy tissues surrounding a malignant tumor under radiation bombardment.
Now the Israeli company BioProtect has come up with a unique biodegradable "balloon" that physically separates cancerous and healthy tissues during radiation therapy for prostate cancer.
BioProtect's CEO, Amir Shiner, says the company's trademarked ProSpace represents a breakthrough in its field. "We're bringing a new product to the market," he says. "There's a clear clinical need for this product in view of the support by numerous publications for escalating radiation doses to prostate cancer patients undergoing radiation therapy. It makes the therapy far more effective."
In a multi-center, international study involving 26 prostate cancer patients, ProSpace was shown to significantly reduce the radiation reaching the rectal wall and consequent associated complications. It therefore allows for radiation at high doses without ill effects, meaning more efficient treatments with fewer treatment sessions at lower cost.
How does it work?
Made from biodegradable polymers, which have a proven safety record, the ProSpace device is filled with saline and implanted using the minimally invasive, well-established technique of transperineal insertion commonly used at outpatient centers.
The balloon remains inflated throughout the radiation therapy treatment. It then dissolves and reabsorbs into the body within three to six months, eliminating the need for removal. Patients involved in the trial reported that they felt no discomfort or pain from the implanted balloon, aside from mild and temporary discomfort at the access area at the perineum.
Because radiation therapy is a well-established, effective and widely accepted form of treatment for many types of cancer, it is expected that the BioProtect device can be used to implement safer and more effective radiation therapies for a variety of cancers.
"There's a strong need to have such a protection device," says Shiner, noting that BioProtect is not alone in this market. "There is one company that provides a gel product that is injected for the same need. Competition is always good - the feedback we've received from physicians is that they far prefer our product. It has a clear advantage in that it is reproducible. Due to its reproducible shape and size, and well-defined boundaries under a CT scan, it helps the doctor to administer the treatment effectively."
Europe first
In October 2010, ProSpace received the CE Mark, ensuring that it conforms to European regulatory requirements. BioProtect is now establishing a marketing network in Europe. "In April we started in Italy, and have now signed distribution agreements in five European countries," reports Shiner. "We're in the middle of a soft-launch process in those countries, and are negotiating to expand further in Europe, where we already have initial sales."
Last July, the ProSpace device received Israeli Health Ministry approval for marketing. In January, the company will launch a study utilizing its balloon for an innovative radiation therapy protocol at several medical centers in Israel.
In the United States, the company has already carried out a pilot study for the Food and Drug Administration and is now discussing with the FDA further clinical requirements to obtain clearance, says Shiner.
"We're a small company, based in Kfar Saba. Our R&D team and manufacturing are on site, while we are strongly focused on clinical activities, marketing and sales," he adds.
The company has already raised funds from three groups of investors: Xenia Venture Capital, which operates the technological incubator in Kiryat Gat where the company began as a startup; Virginia Life Science Investments, which invests in several Israeli healthcare companies; and the JumpStart NJ Angel Network. "We also have other private investors," notes Shiner. "Currently, we're working on more significant fundraising to take us to the next stage."

Last modified onMonday, 29 July 2013 11:14

Leave a comment

Make sure you enter the (*) required information where indicated. HTML code is not allowed.

back to top
40% off 4 or more products. Enter code 40SPRING at checkout. Get a discount with a minimum purchase at PaulFredrick.com
Travel Deals to top Destinations. Get yours now

Sections

Jewish Traditions

About Us

Community

Cooperations

Follow Us